For decades, taking low-dose aspirin every day was widely recommended as an easy way to prevent heart attacks and strokes. But that advice has changed.

Triptans are contraindicated in patients with cardiovascular diseases ... 65 mg + dichloralphenazone 100 mg Midrin® ‡ As above, see APAP dosage Aspirin 650 mg + butalbital 50 mg Axotal ...

The primary end point was the first event of a new-onset major adverse cardiovascular event (MACE ... different between groups (101.4 mg vs 100.9 mg) and the average daily dose was 100.9 mg for ...

Studies have shown a dose-dependent increase in the rate of adverse cardiovascular effects when ... M Droperidol 100 mg oral, levomepromazine, haloperidol 50 mg oral, pimozide, oxazepam ...

The primary efficacy outcome was a composite of major adverse cardiovascular events (MACE ... two groups based on subsequent antithrombotic therapy: (1) aspirin plus rivaroxaban 2.5 mg/bid; (2) ...

Neuro-humoral, beta-blocker and diuretic therapy were initiated, maintaining aspirin ... 4 Friedrich MG, Sechtem U, Schultz-Menger J, Holmvang G, Alakija P, Cooper LT, et al; International Consensus ...

A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...

Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic ...

Safe aspirin elimination in patients with HeartMate 3 LVAD reduces bleeding risk, offering key clinical practice insights.